Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 9, 2000 - Issue 4
Submit an article Journal homepage
78
Views
18
CrossRef citations to date
0
Altmetric
Drug Evaluation

Remacemide: current status and clinical applications

Steven C Schachter Departments of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, K-478, Boston, MA 02215, USA. [email protected]
&
Daniel Tarsy Departments of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, K-478, Boston, MA 02215, USA. [email protected]
Pages 871-833 | Published online: 24 Feb 2005

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ronald F Tuma, Jeffrey J Legos & Frank C Barone. (2002) Pharmacological interventions for stroke: failures and future. Expert Opinion on Investigational Drugs 11:5, pages 603-614.
Read now
Benjamin Drukarch & Freek L van Muiswinkel. (2001) Neuroprotection for Parkinson’s disease: a new approach for a new millennium. Expert Opinion on Investigational Drugs 10:10, pages 1855-1868.
Read now

Articles from other publishers (16)

Vinod Ugale, Rutuja Deshmukh, Deepak Lokwani, P. Narayana Reddy, Saurabh Khadse, Prashant Chaudhari & Prasad P. Kulkarni. (2023) GluN2B subunit selective N-methyl-D-aspartate receptor ligands: Democratizing recent progress to assist the development of novel neurotherapeutics. Molecular Diversity.
Crossref
Ranju Bansal & Ranjit Singh. (2018) Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review. Medicinal Research Reviews 38:4, pages 1126-1158.
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs 96 97 .
R. Scott Obach. (2013) Pharmacologically Active Drug Metabolites: Impact on Drug Discovery and Pharmacotherapy. Pharmacological Reviews 65:2, pages 578-640.
Crossref
Zhao-Hui Guo, Feng Li & Wei-Zhi Wang. (2009) The mechanisms of brain ischemic insult and potential protective interventions脑缺血的损伤机制及其保护性干预. Neuroscience Bulletin 25:3, pages 139-152.
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 3029 .
Gareth R. LewisGerry SteeleLorraine McBrideAlastair J. FlorenceAlan R. KennedyNorman ShanklandWilliam I. F. DavidKenneth ShanklandSimon J. Teat. (2005) Hydrophobic vs. Hydrophilic:  Ionic Competition in Remacemide Salt Structures. Crystal Growth & Design 5:2, pages 427-438.
Crossref
L. Ley & T. Herdegen. 2004. Brain Damage and Repair. Brain Damage and Repair 589 615 .
R.R Leker & M.Y Neufeld. (2003) Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia. Brain Research Reviews 42:3, pages 187-203.
Crossref
Graeme J Sills, Sarah Santangeli, Gerard Forrest & Martin J Brodie. (2002) Influence of cytochrome P450 induction on the pharmacokinetics and pharmacodynamics of remacemide hydrochloride. Epilepsy Research 49:3, pages 247-254.
Crossref
Martin J. Brodie, Stephen J. Wroe, Andrew D.P. Dean, Thomas A.H. Holdich, John Whitehead & John W. Stevens. (2002) Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential Analysis. Epilepsy & Behavior 3:2, pages 140-146.
Crossref
E.J Popke, R Patton, G.D Newport, L.G Rushing, C.M Fogle, R.R Allen, E.C Pearson, T.G Hammond & M.G Paule. (2002) Assessing the potential toxicity of MK-801 and remacemide:. Neurotoxicology and Teratology 24:2, pages 193-207.
Crossref
Sarah Santangeli, Graeme J. Sills, Trevor W. Stone & Martin J. Brodie. (2002) Differential effects of remacemide and desglycinyl-remacemide on epileptiform burst firing in the rat hippocampal slice. Neuroscience Letters 321:1-2, pages 33-36.
Crossref
Jeffrey K. Aronson. 2002. 78 109 .
Martin J Brodie. (2001) To the Editor. Epilepsy & Behavior 2:6, pages 616.
Crossref
Martin J. Brodie. (2001) Monotherapy trials: prerequisite data. Epilepsy Research 45:1-3, pages 61-64.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.